Abbott Laboratories ABT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Medtronic Continuous Glucose Monitor Gets FDA Approval, Partners with Abbott
-
Trending: Abbott Labs Told to Pay $495 Million in Compensation in Infant-Formula Verdict
-
Abbott Labs, Reckitt see further stock-price pressure after $495 million jury award
-
Abbott Laboratories Shares Tumble on $495 Million Infant Formula Verdict
-
What are the most profitable stocks of all time? The answer might surprise you.
-
Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise
-
Abbott Laboratories on Pace for Largest Percent Decrease Since October 2023 — Data Talk
-
Abbott Labs' first-quarter results top estimates amid strong medical-device sales
Trading Information
- Previous Close Price
- €100.58
- Day Range
- €100.84–101.26
- 52-Week Range
- €85.66–111.10
- Bid/Ask
- €101.04 / €101.60
- Market Cap
- €176.18 Bil
- Volume/Avg
- 0 / 1
Key Statistics
- Price/Earnings (Normalized)
- 24.62
- Price/Sales
- 4.70
- Dividend Yield (Trailing)
- 1.96%
- Dividend Yield (Forward)
- 1.94%
- Total Yield
- 2.22%
Company Profile
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Value
- Total Number of Employees
- 114,000
- Website
- https://www.abbottinvestor.com
Competitors
Valuation
|
Metric
|
ABT
|
BSX
|
MDT
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.62 | 37.38 | 17.05 |
Price/Book Value | 4.80 | 6.02 | 2.39 |
Price/Sales | 4.70 | 8.10 | 3.62 |
Price/Cash Flow | 17.85 | 31.26 | 15.81 |
Price/Earnings
ABT
BSX
MDT
Financial Strength
|
Metric
|
ABT
|
BSX
|
MDT
|
|---|---|---|---|
Quick Ratio | 1.18 | 0.95 | 1.35 |
Current Ratio | 1.68 | 1.61 | 2.13 |
Interest Coverage | 11.17 | 8.66 | 7.66 |
Quick Ratio
ABT
BSX
MDT
Profitability
|
Metric
|
ABT
|
BSX
|
MDT
|
|---|---|---|---|
Return on Assets (Normalized) | 10.75% | 9.33% | 7.66% |
Return on Equity (Normalized) | 20.45% | 17.03% | 13.69% |
Return on Invested Capital (Normalized) | 14.91% | 11.85% | 9.84% |
Return on Assets
ABT
BSX
MDT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Kmhcffyl | Gqdbksj | $195.6 Bil | |||
| Stryker Corp
SYK
| Zqkfcfrwb | Qcry | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Kkmclwr | Jxplt | $122.7 Bil | |||
| Medtronic PLC
MDT
| Ndqrtgbp | Thspkb | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Dhqsddjy | Jlwlmk | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Wvmj | Yzrrd | $30.7 Bil | |||
| DexCom Inc
DXCM
| Xqxjvbnvq | Wgnw | $27.0 Bil | |||
| Steris PLC
STE
| Kjrmypv | Lzhfrn | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Wjygchrrl | Gcj | $22.0 Bil | |||
| Insulet Corp
PODD
| Dglzkpqhmx | Qndvlt | $16.3 Bil |
United States